New evidence
Folic acid improved cognitive scores in a controlled trial (P<0.05) – but the benefit appeared only in patients with cerebral small vessel disease.
This single, early trial suggests folic acid may help offset cognitive decline in people with small vessel disease, but because it is among the first such studies, the result needs confirmation and may not extend to healthier populations.
In a double-blind trial, patients with cognitive impairment due to cerebral small vessel disease who took folic acid scored better on two standard cognitive tests compared to placebo, with the difference reaching statistical significance. However, this is one of the first indexed studies on this specific combination, so the finding should be treated as preliminary rather than definitive. The benefit was seen only in this clinical group, meaning it does not automatically apply to everyone.
Where this fits in the evidence
Pillser has synthesized 3 studies on Vitamin B9 for Improved Cognitive Function — overall evidence strength: Low.
Across 3 studies, 2 reported beneficial effects (one moderate, one small) and 1 reported no effect (small, non-significant). Effects were mixed in magnitude. The median study duration was 176 days, and the evidence primarily comes from clinical populations with cognitive impairment or low folate levels.
The study
- Randomized Controlled Trial (RCT)
- 2026-01
- The journal of prevention of Alzheimer's disease
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.